These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27570478)

  • 1. Multiple Growth Factors, But Not VEGF, Stimulate Glycosaminoglycan Hyperelongation in Retinal Choroidal Endothelial Cells.
    Al Gwairi O; Osman N; Getachew R; Zheng W; Liang XL; Kamato D; Thach L; Little PJ
    Int J Biol Sci; 2016; 12(9):1041-51. PubMed ID: 27570478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor-stimulated versican synthesis but not glycosaminoglycan elongation in vascular smooth muscle is mediated via Akt phosphorylation.
    Osman N; Getachew R; Thach L; Wang H; Su X; Zheng W; Little PJ
    Cell Signal; 2014 May; 26(5):912-6. PubMed ID: 24462709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin regulates vascular smooth muscle cell proteoglycan synthesis via PAR-1 and multiple downstream signalling pathways.
    Ivey ME; Little PJ
    Thromb Res; 2008; 123(2):288-97. PubMed ID: 18571697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic physiology in age related macular degeneration.
    Stefánsson E; Geirsdóttir A; Sigurdsson H
    Prog Retin Eye Res; 2011 Jan; 30(1):72-80. PubMed ID: 20951826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents.
    de Dios ST; Frontanilla KV; Nigro J; Ballinger ML; Ivey ME; Cawson EA; Little PJ
    J Diabetes Complications; 2007; 21(2):108-17. PubMed ID: 17331859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrido-pyrimidine derivative CYC10424 inhibits glycosaminoglycan changes on vascular smooth muscle-derived proteoglycans and reduces lipoprotein binding.
    Ballinger ML; Osman N; Wilks AF; Su S; Burns CJ; Bu X; Little PJ
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):403-12. PubMed ID: 19033819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate modifies human vascular smooth muscle proteoglycans and reduces lipoprotein binding.
    Nigro J; Ballinger ML; Dilley RJ; Jennings GL; Wight TN; Little PJ
    Diabetologia; 2004 Dec; 47(12):2105-13. PubMed ID: 15592811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin inhibits PDGF-stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cells.
    Little PJ; Rostam MA; Piva TJ; Getachew R; Kamato D; Guidone D; Ballinger ML; Zheng W; Osman N
    J Pharm Pharmacol; 2013 Jul; 65(7):1055-63. PubMed ID: 23738733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDGF beta-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL.
    Getachew R; Ballinger ML; Burch ML; Reid JJ; Khachigian LM; Wight TN; Little PJ; Osman N
    Endocrinology; 2010 Sep; 151(9):4356-67. PubMed ID: 20610572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor-mediated hyper-elongation of glycosaminoglycan chains on biglycan requires transcription and translation.
    Yang SN; Burch ML; Getachew R; Ballinger ML; Osman N; Little PJ
    Arch Physiol Biochem; 2009 Jul; 115(3):147-54. PubMed ID: 19580379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration.
    Bhutto IA; McLeod DS; Hasegawa T; Kim SY; Merges C; Tong P; Lutty GA
    Exp Eye Res; 2006 Jan; 82(1):99-110. PubMed ID: 16019000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional and posttranscriptional regulators of biglycan in cardiac fibroblasts.
    Tiede K; Melchior-Becker A; Fischer JW
    Basic Res Cardiol; 2010 Jan; 105(1):99-108. PubMed ID: 19701788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of endothelial-cell-conditioned medium on proteoglycan synthesis in cultured smooth muscle cells from pig aorta.
    Berrou E; Breton M; Deudon E; Picard J
    J Cell Physiol; 1988 Dec; 137(3):430-8. PubMed ID: 3142885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual Smad2 linker region phosphorylation sites determine the expression of proteoglycan and glycosaminoglycan synthesizing genes.
    Kamato D; Burch M; Zhou Y; Mohamed R; Stow JL; Osman N; Zheng W; Little PJ
    Cell Signal; 2019 Jan; 53():365-373. PubMed ID: 30423352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of Ki11502 as a potent inhibitor of PDGF beta receptor-mediated proteoglycan synthesis in vascular smooth muscle cells.
    Getachew R; Ballinger ML; Burch ML; Little PJ; Osman N
    Eur J Pharmacol; 2010 Jan; 626(2-3):186-92. PubMed ID: 19818754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL.
    Ballinger ML; Ivey ME; Osman N; Thomas WG; Little PJ
    Atherosclerosis; 2009 Aug; 205(2):451-7. PubMed ID: 19217622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage secretory products selectively stimulate dermatan sulfate proteoglycan production in cultured arterial smooth muscle cells.
    Edwards IJ; Wagner WD; Owens RT
    Am J Pathol; 1990 Mar; 136(3):609-21. PubMed ID: 2316626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bruch's membrane diffusivity for vascular endothelial growth factors may explain variable response to wet age-related macular degeneration treatment: clinical implications.
    Peddada RR
    Med Hypotheses; 2014 Dec; 83(6):835-7. PubMed ID: 25468789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAGE ligand upregulation of VEGF secretion in ARPE-19 cells.
    Ma W; Lee SE; Guo J; Qu W; Hudson BI; Schmidt AM; Barile GR
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1355-61. PubMed ID: 17325184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Sema3C Mutant Resistant to Cleavage by Furin (FR-Sema3C) Inhibits Choroidal Neovascularization.
    Toledano S; Lu H; Palacio A; Ziv K; Kessler O; Schaal S; Neufeld G; Barak Y
    PLoS One; 2016; 11(12):e0168122. PubMed ID: 28036336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.